Our Expertise
With deep expertise across the product lifecycle, we help clients navigate the complexities, turning challenges into opportunities. Our experience ensures strategic guidance and actionable insights that drive success from development through launch and beyond.
Early development & Phase II
Identifying and evaluating opportunities
Landscape assessments
Disease area & indication sequencing strategy
Analogue assessments
Define early value
Payer rationalised trial design
Evidence gap analyses
Early scientific advice
Supporting Go/ No Go decision-making
Access enabled TPP development and testing
Access and commercial opportunity assessment
Product positioning
Before & during Phase III
Preparing the market for success
Early access strategies
Launch strategy and sequencing
Pricing and access strategies
Payer and stakeholder research
Substantiate value
Global value dossiers
Economic model development
Evidence synthesis, SLRs & TLRs
Support value
Value propositions
Value narratives
Value message testing
Filing & launch
Fine-tune access strategy
Innovative contracting strategies
Tendering strategies
Negotiation pathways
Prepare for stakeholder communication
HTA submissions
Consensus statements
Manuscripts
Ensure stakeholder engagement excellence
Objection handlers
Negotiation excellence training
Mock negotiations
Post-launch
Improve and defend uptake
Lifecycle management strategies
Competitor insights
Access and reimbursement trackers
Strategic lifecycle management
Model adaptations
Incorporating new and real-world evidence in value messaging
Local country adaptations to value communication materials
Defend market share
Tender and contracting excellence
Beyond price differentiation
Wargaming and defence strategies
Market Access Director
Global Market Access and Pricing Lead
French payer, former member of the Transparency Committee
Strategic Access and Pricing Director
Global Head of New Product Development
Global Reach
Trusted Partner
Industry Expertise
Long-Term Partnerships
Broad Experience